It has been reported that SLC7A11 and SLC38A1 expression is upregulated in BC tissues and cells, and high SLC7A11 and SLC38A1 expression levels are associated with a poor prognosis in patients with BC [24]. This evidence concerns the gene SLC7A11 and breast cancer.